Jarvik Heart, Inc. is a leading medical device company based in New York, NY, specializing in the development and manufacturing of innovative ventricular assist devices (VADs) for the treatment of heart failure. Their flagship products, the Jarvik 2000 and the Jarvik 2015, offer small size, silent operation, simplicity, and portability, providing patients with a high level of comfort and control. With a strong focus on quality assurance and continuous improvement, Jarvik Heart is dedicated to improving the lives of individuals suffering from heart disease through their advanced implantable devices.
Known for their groundbreaking technology, Jarvik Heart has received FDA approval for clinical trials of miniature heart assist devices for infants and children, demonstrating their commitment to providing solutions for patients of all ages. With a global presence, their products are available in several countries, including the United States, Croatia, Czech Republic, France, Germany, Greece, Hungary, Italy, Japan, Switzerland, and the United Kingdom. Through their ongoing research and development efforts, Jarvik Heart continues to push the boundaries of medical innovation, offering hope and freedom to individuals in need of life-saving cardiac support.
Generated from the website